T83.713
Erosion of implanted urethral bulking agent to surrounding organ or tissue
Clinical Classification Guidelines
Medical Intelligence & Overview
Erosion of an implanted urethral bulking agent is a rare complication that can occur after treatment for urinary incontinence. It involves the migration or breakdown of the injected material, which was originally placed to help support the urethra. This condition can affect surrounding tissues or organs, leading to discomfort or further medical issues. Awareness of this condition is important for patients who have undergone urethral bulking procedures, as early detection can help manage symptoms effectively.
Causes & Symptoms
Clinical Causes: Improper placement of the bulking agent during initial procedure Material overgrowth or tissue reaction leading to erosion Infection at the site of implantation Chronic pressure or mechanical stress on the injected area Use of certain types of bulking materials that are more prone to erosion Patient-specific factors such as tissue fragility or autoimmune response
Key Symptoms: New or worsening urinary incontinence Pain or discomfort in the pelvic or urethral area Blood in the urine (hematuria) Repeated urinary tract infections Feeling of mass or foreign body sensation near the urethra Urinary urgency or difficulty urinating Potential leakage of urine or other fluids from the urethra
Diagnostic & Treatment
Diagnosis Path: Diagnosis typically involves a detailed medical history review and physical examination. Imaging tests, such as ultrasound or cystoscopy, are commonly used to observe the location of the bulking material and assess tissue integrity. These procedures help determine whether erosion has occurred and its extent, guiding further management decisions.
Treatment Protocols: Treatment of urethral bulking agent erosion depends on the severity and symptoms. Interventions may include: - Removal or repositioning of the compromised material - Surgical repair of affected tissues - Use of antibiotics if an infection is present - Monitoring for potential complications or recurrence after treatment In some cases, alternative procedures for managing urinary incontinence may be considered if erosion recurs or persists.
Clinical Advice & FAQs
Billing Guidance
Is T83.713 a billable ICD-10 code?
Yes, T83.713 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report T83.713?
Clinical documentation must specify the nature of Erosion of implanted urethral bulking agent to surrounding organ or tissue and any associated comorbidities for accurate reporting.
Cite this Clinical Reference